ADC Therapeutics SA
1.74
0.03 (1.75%)
At close: Jan 15, 2025, 2:43 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -240.05M -155.80M -230.03M -246.29M -116.48M -123.10M -89.86M
Depreciation & Amortization 3.27M 2.33M 2.63M 2.19M 1.65M 740.00K 341.00K
Stock-Based Compensation 13.49M 49.32M 60.48M 37.59M 1.12M 469.00K 980.00K
Other Working Capital -8.30M 18.40M 6.16M 10.44M -2.34M -1.14M -1.80M
Other Non-Cash Items 23.23M 1.07M -24.70M 25.10M -1.19M -891.00K 36.00K
Deferred Income Tax 37.10M -708.00K -21.48M 327.00K 1.21M 935.00K 48.00K
Change in Working Capital 44.27M -33.01M -20.28M 12.36M -7.88M 481.00K 13.51M
Operating Cash Flow -118.69M -136.79M -233.38M -168.73M -121.58M -121.36M -74.94M
Capital Expenditures -3.22M -2.30M -6.38M -2.81M -2.15M -2.47M -3.16M
Acquisitions n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a -210.00K -297.00K -19.00K -100.00K -36.00K -92.00K
Investing Cash Flow -3.22M -2.51M -6.67M -2.83M -2.25M -2.51M -3.25M
Debt Repayment n/a -2.71M 48.61M 61.75M -1.00M n/a n/a
Common Stock Repurchased n/a -221.00K n/a n/a -141.00K -24.00K n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 73.88M -4.32M 218.78M 54.00K 101.61M -24.00K n/a
Financial Cash Flow 73.88M -593.00K 267.39M 494.97M 100.51M -24.00K 197.24M
Net Cash Flow -47.84M -140.10M 27.35M 323.64M -23.26M -123.94M 119.08M
Free Cash Flow -121.90M -139.09M -239.75M -171.54M -123.73M -123.83M -78.10M

Create Price Alert on ADCT

Your price alert will notify you when the stock price is above 1.74.

Add to Watchlist